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Background
In an effort to improve product yield of mammalian cell
lines, we have previously demonstrated that our proprie-
tary DNA elements, Selexis Genetic Elements (SGEs),
increase the transcription of a given transgene, thus boost-
ing the overall expression of a therapeutic protein drug in
mammalian cells [1]. However, there are additional cellu-
lar bottlenecks, notably in the molecular machineries of
the secretory pathways. Most importantly, mammalian
cells have some limitations in their intrinsic capacity to
manage high level of protein synthesis as well as folding
recombinant proteins. These bottlenecks often lead to
increased cellular stress and, therefore, low production
rates.
Material and Methods
Our specific approach involves CHO cell line engineering.
We constructed CHO-M libraries based upon the CHO-
M genome and transcriptome and using unique proprie-
tary transposon vectors harboring SGE DNA elements to
compensate for rate-limiting factors [2]. Each CHO-Mplus
library displays a diversity of auxiliary proteins involved in
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Figure 1 The iterative application of the CHO-Mplus libraries enabled >10 fold increase in productivity of ScFv:Fc without changes in
gene copy number or transcription level of gene of interest.
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secretory pathway machineries and cellular metabolism.
Collectively, the libraries address a broad range of expres-
sion issues.
Results
Figure 1 shows that our CHO-Mplus libraries enabled
the selection of a clonal cell line expressing 12 fold
more product by comparison to the unmodified host
cell [3].
Conclusions
Our results demonstrate that components of the secre-
tory and processing pathways can be limiting, and that
engineering of the metabolic pathway (‘omic’ profiling)
improves the secretion efficiency of therapeutic proteins
from CHO cells.
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